Market Research Report
Bone Graft Substitutes | Medtech 360 | Market Insights | Global | 2019
|Published by||Decision Resources Group - Medtech||Product code||507593|
Delivery time: 1-2 business days
|Bone Graft Substitutes | Medtech 360 | Market Insights | Global | 2019|
|Published: March 31, 2019||Content info:||
Despite challenging reimbursement environments, evolving regulatory requirements, limited clinical evidence for newer products, and lingering negative publicity surrounding key products, the global market for BGS will undergo moderate growth due to a good balance of rapidly expanding emerging markets in the Asia Pacific and Latin America regions and developed economies in the US and Europe.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for BGS in the US, Europe, Asia Pacific, and Latin America across a 10-year period.
How will companies use the regulatory landscape to their advantage in the US market?
How have and how will companies continue to ensure a successful product launch following approval?
Which countries have limited or a complete lack of reimbursement for these products?
What strategies can companies use to promote their products when reimbursement is lacking?
How are domestic manufacturers' product offerings evolving in comparison to products offered by MNCs?
In which countries do domestic companies hold particularly high market shares, and why?
Author(s): Robert Cohen, BSc
Robert is an analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in aesthetic injectables, therapeutic botulinum toxin, cosmetic threads, breast reconstruction, and bone graft substitutes. Prior to joining DRG, Robert worked as a clinical research assistant in hematology. Robert holds an Honors Bachelor's degree in Immunology from McGill University.